IPG Investment Advisors LLC Has $11.13 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

IPG Investment Advisors LLC lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 26.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,192,589 shares of the pharmacy operator's stock after selling 436,146 shares during the quarter. Walgreens Boots Alliance comprises 2.5% of IPG Investment Advisors LLC's portfolio, making the stock its 10th largest position. IPG Investment Advisors LLC owned approximately 0.14% of Walgreens Boots Alliance worth $11,127,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in WBA. Swedbank AB boosted its holdings in Walgreens Boots Alliance by 45.3% during the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock worth $5,559,000 after buying an additional 185,762 shares in the last quarter. Sunbelt Securities Inc. lifted its position in shares of Walgreens Boots Alliance by 82.8% in the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator's stock worth $1,249,000 after purchasing an additional 63,149 shares in the last quarter. Merit Financial Group LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $326,000. FMR LLC grew its position in Walgreens Boots Alliance by 2.5% during the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator's stock valued at $29,200,000 after purchasing an additional 80,525 shares in the last quarter. Finally, Redwood Investment Management LLC increased its stake in Walgreens Boots Alliance by 67.0% in the 3rd quarter. Redwood Investment Management LLC now owns 210,179 shares of the pharmacy operator's stock valued at $1,903,000 after buying an additional 84,303 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on WBA shares. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. StockNews.com started coverage on Walgreens Boots Alliance in a research report on Thursday. They issued a "hold" rating for the company. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Trading Down 1.2 %

Shares of WBA traded down $0.13 on Thursday, reaching $11.05. 8,278,036 shares of the company's stock were exchanged, compared to its average volume of 20,750,123. The stock has a market capitalization of $9.55 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The business has a 50 day moving average price of $10.79 and a two-hundred day moving average price of $9.95. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $19.48.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the business posted $0.66 EPS. The firm's revenue was up 7.6% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.